Your session is about to expire
← Back to Search
Vasodilator
Vascana for Raynaud's Disease
Phase 3
Waitlist Available
Research Sponsored by MediQuest Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
clinical diagnosis of Raynaud's phenomenon as determined by a history of cold sensitivity with pain, numbness, and/or tingling along with pallor or cyanosis of the fingers
a history of at least two Raynaud's events during a typical winter day
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
Study Summary
The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon.
Eligible Conditions
- Raynaud's Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Response rate as measured by changes in severity of the Raynaud's symptom most bothersome to the individual patient (Pain, Numbness, or Tingling)
Secondary outcome measures
Changes from baseline in duration of Raynaud's attacks
Changes from baseline in number of Raynaud's attacks
Changes from baseline in overall disease severity measures
+4 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: VascanaActive Control1 Intervention
Group II: VehiclePlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
MediQuest TherapeuticsLead Sponsor
10 Previous Clinical Trials
722 Total Patients Enrolled
Jeff Gregory, MDStudy DirectorMediQuest Therapeutics
3 Previous Clinical Trials
219 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger